Humanoid Robotics M&A: what is happening now?

What are all the recent deals and acquisitions in humanoid robotics?

When we look at all the M&A deals in humanoid robotics over the last 24 months, we find 7 core deals.

The market is still young, but it is no longer quiet: the recent buyers include autonomy companies, AI platforms, Big Tech groups, avatar companies, and public-market capital.

Date	Target	Acquirer	Value	Strategic rationale	Status and additional comment
2026-06-24	Agility Robotics	Churchill Capital Corp XI	$2.5B pre-money equity value	Agility gets public-market capital to scale Digit, its humanoid robot for logistics and manufacturing.	Announced, expected to close in 2026. This is the largest core humanoid robotics transaction in the period and the first real public-market benchmark for a US humanoid robotics company.
2026-05-01	Assured Robot Intelligence	Meta	Undisclosed	Meta buys humanoid robot intelligence talent, especially around robot foundation models, adaptation, and control.	Closed / announced. This is more a “robot brain” acquisition than a robot-body acquisition.
2026-03-24	Fauna Robotics	Amazon	Undisclosed	Amazon buys Sprout, a small humanoid robot designed for homes, schools, labs, and social environments.	Closed / announced. The speed matters: Fauna was acquired only a short time after Sprout became visible publicly.
2026-02-12	A-Lab	AVITA	Undisclosed	AVITA moves from AI avatars into physical android robots by acquiring A-Lab’s domestic humanoid robot capability.	Closed / announced. This deal is important because it shows humanoid M&A outside the US and outside warehouse robotics.
2026-01-06	Mentee Robotics	Mobileye	$900M	Mobileye expands from autonomous driving into physical AI and humanoid robotics by acquiring a vertically integrated humanoid platform.	Announced, expected to close in Q1 2026. This is the clearest example of an autonomy company buying into humanoids at scale.
2025-04-14	Pollen Robotics	Hugging Face	Undisclosed	Hugging Face connects open-source AI software with Reachy 2, an open-source humanoid robot platform.	Closed / announced. This is the key open-source humanoid robotics deal in the period.
2025-01-27	Kind Humanoid	1X Technologies	Undisclosed	1X consolidates another humanoid team working on safe humanoids for everyday environments.	Closed / announced. This is a smaller intra-humanoid consolidation deal, but it still matters because both companies were directly building humanoid robots.

Is humanoid robotics M&A actually active now?

Humanoid robotics M&A is active now, but it is still a selective strategic market, not a high-volume consolidation market.

Over the last 24 months, we count 7 core deals, which is enough to show real movement but still far from the hundreds of transactions we would expect in a mature software or industrial automation category.

The useful point is not just the number of deals but the mix. In the earlier part of the period, the deals were mostly ecosystem consolidation: 1X buying Kind Humanoid and Hugging Face buying Pollen Robotics. In the latest part of the period, the buyers became much more diverse: Mobileye, Amazon, Meta, AVITA, and Churchill Capital all entered through acquisitions or a public-market transaction.

That changes the read. These buyers are not all solving the same problem. Mobileye is bringing autonomy software into humanoids. Amazon is testing consumer and social robotics optionality. Meta is buying robot intelligence talent. AVITA is moving from avatars to physical androids. Agility is using public-market capital to scale deployments. All things considered, humanoid robotics M&A is active because the buyer universe has expanded, not because deal volume is already massive.

Is humanoid robotics M&A accelerating recently?

Humanoid robotics M&A is accelerating clearly. We found 2 core deals in the previous 12 months and 5 core deals in the last 12 months, so recent deal count is 2.5x higher than the prior period.

The acceleration is even sharper if we zoom into 2026. From January to June 2026 alone, we count 5 core transactions: Mobileye / Mentee, AVITA / A-Lab, Amazon / Fauna, Meta / ARI, and Agility / Churchill. That means every core deal in the latest 12-month period happened inside roughly six months.

That clustering is the part to watch. In a young market, one big acquisition can be dismissed as opportunistic. Five separate transactions in half a year, across autonomy, Big Tech, avatars, AI research, and public-market financing, point to a real change in market behavior. The market went from occasional founder-led consolidation to strategic buyers positioning before commercial scale arrives.

If you want more recent data on this point, please see our latest humanoid robotics market report.

Are big companies buying humanoid robotics companies now?

Yes, big companies are now buying humanoid robotics assets. This is one of the biggest changes in the last 12 months.

Mobileye acquired Mentee Robotics for $900M, which is a large number for a company still moving toward commercial deployment. Amazon bought Fauna Robotics, a two-year-old startup building Sprout, a small humanoid robot for social and human environments. Meta bought Assured Robot Intelligence to strengthen its humanoid robot AI capability. Hugging Face, although not Big Tech in the Amazon or Meta sense, is also strategically important because it brings a major AI developer platform into open-source robotics hardware.

The non-obvious point is that these buyers are entering from different home bases. Mobileye comes from self-driving and production-grade autonomy. Amazon comes from logistics robotics, Alexa, and consumer hardware experience. Meta comes from AI models, embodied intelligence, and long-term computing platforms. Hugging Face comes from open-source AI infrastructure.

So humanoid robotics is no longer being treated as a standalone robotics niche. It is becoming a strategic extension of AI, autonomy, consumer platforms, and developer ecosystems.

Is the money going into robot bodies or robot brains these days?

The money is going into both, but the market is starting to treat the brain layer as the more strategic bottleneck. Most core targets still have physical robot platforms: Mentee has a vertically integrated humanoid, Pollen has Reachy 2, Fauna has Sprout, A-Lab builds android robots, Kind built Mona, and Agility has Digit.

But the recent buyer logic tells a deeper story. Meta / ARI is almost entirely about humanoid robot intelligence, not a scaled hardware product. Mobileye / Mentee is valuable because Mobileye can apply autonomy, perception, production discipline, and AI software to Mentee’s humanoid platform. Hugging Face / Pollen matters because Hugging Face can connect open-source models, datasets, developer tools, and robotics hardware.

In plain English: the body gets the headline, but the brain often explains why the buyer cares. A humanoid robot body without learning, control, simulation, data, and safe deployment is hard to commercialize. The best acquisitions are attempts to connect hardware with the software stack that could make humanoids useful in the real world.

If you want more recent data on this point, please see our latest humanoid robotics market report.

Are buyers paying real prices for humanoid robotics companies yet?

Yes, buyers are already paying serious prices for the most strategic humanoid robotics assets.

Out of 7 core deals, only 2 disclosed meaningful values, but those two disclosed transactions are large: $900M for Mobileye / Mentee and $2.5B pre-money equity value for Agility / Churchill. Together, that creates $3.4B of disclosed core transaction value in 24 months.

The important interpretation is that disclosed value is concentrated, not spread evenly. Five deals were undisclosed, which means the market still has weak pricing transparency. We cannot build reliable revenue multiples because most targets are pre-scale, pre-commercial, or strategic technology acquisitions. Still, the two disclosed events are large enough to anchor the category.

Compared with the actual number of deals, the valuation point is unusually strong. A market with only 7 core transactions but $3.4B of disclosed value is not being valued like a small robotics hobby category. It is being priced like an option on a much larger physical AI market.

That does not mean every humanoid company is worth a unicorn valuation. But it does show that strategic buyers and investors are willing to pay up when they believe the platform can become foundational.

Are humanoid robotics companies being bought before they are fully commercial?

Yes, humanoid robotics companies are being bought before full commercial maturity. That is one of the clearest patterns in recent humanoid robotics M&A.

Mentee was acquired before broad commercialization, with proof-of-concept deployments expected first and commercialization later. Fauna was acquired very early, shortly after Sprout became public. Meta bought ARI for robot intelligence capability rather than for an installed base of robots. 1X bought Kind Humanoid for team, technology, and shared product direction, not for a mature revenue stream.

This is exactly what early strategic M&A looks like in a frontier market. Buyers are not waiting for the financials to become obvious because, by then, the best teams and platforms may already be too expensive or locked up. All things considered, humanoid robotics M&A is still more about future control than current revenue.

If you want more recent data on this point, please see our latest humanoid robotics market report.

Is humanoid robotics M&A still mostly about small team acquisitions?

No, humanoid robotics M&A is no longer mostly about small team acquisitions. Some deals are clearly talent-heavy, especially Meta / ARI and 1X / Kind, but the market now also has platform acquisitions and capital-market events.

Mobileye / Mentee is the strongest platform-acquisition example. Mobileye is not just hiring a few roboticists; it is buying a vertically integrated humanoid company and placing humanoids beside autonomous driving as part of its physical AI strategy. Agility / Churchill is even more different because it is not a classic acquisition at all. It is a public-market transaction designed to fund production, deployments, and scale.

Hugging Face / Pollen sits in the middle. It includes a team, but it also includes Reachy 2, an open-source humanoid platform that can be sold, modified, and used by developers. So the market has split into three deal types: talent deals, platform deals, and financing / listing deals. That is a more mature structure than small team acqui-hires only.

Is commercial traction starting to matter in humanoid robotics M&A?

Yes, commercial traction is starting to matter, especially for the largest valuation events. Agility is the cleanest example because its deal announcement included more than $300M in multi-year Digit v5 orders, 65,000+ operating hours, deployments in customer facilities, and a pipeline of more than 30 customers.

Those details change the interpretation. Agility is not being valued only on a humanoid demo video but partly on evidence that Digit can work in logistics and manufacturing environments, where customers already understand the labor problem and the task requirements. That makes the valuation more credible than a pure “future robot assistant” story.

Still, commercial traction is not the only currency in this market. Mentee, Fauna, ARI, Kind, and Pollen show that buyers also pay for early platforms, talent, software, and developer ecosystems. The practical conclusion is simple: commercial proof matters most when the valuation is large, while strategic capability can still drive undisclosed acquisitions.

If you want more recent data on this point, please see our latest humanoid robotics market report.

Is humanoid robotics becoming a public-market category now?

Yes, humanoid robotics is starting to become a public-market category. The Agility / Churchill deal is the key event because it gives the market a $2.5B pre-money reference point for a pure-play humanoid robotics company.

This matters because most humanoid robotics exposure has been hard to isolate. Tesla Optimus is inside Tesla. Boston Dynamics is inside Hyundai. Figure, 1X, Apptronik, and many other important companies are private. Agility creates a cleaner benchmark because investors can look at a company focused specifically on humanoid robotics for logistics and manufacturing.

The benchmark is not perfect because Agility is one company with one commercial focus. But it still changes the market conversation. Instead of only asking what humanoid robots could be worth one day, investors can now compare orders, deployments, operating hours, production plans, and public-market valuation. Humanoid robotics is moving from private hype into a more measurable capital-markets phase.

Is humanoid robotics M&A global now, or still mostly US-focused?

Humanoid robotics M&A is global, but US platforms and US capital still shape the market. The 7 core deals touch the US, Israel, France, Japan, and Norway. That is already broader than a purely Silicon Valley story.

The US influence is still obvious. Amazon, Meta, Churchill Capital, and the US side of Hugging Face all matter. Kind was based in Palo Alto. Agility is a US company. Even when the target is outside the US, the buyer or capital-market logic often connects back to US technology platforms or US investors.

The more interesting detail is that each region brings a different flavor. Israel contributes autonomy through Mobileye and Mentee. France contributes open-source robotics through Pollen and Hugging Face. Japan contributes android robotics through AVITA and A-Lab. Norway contributes humanoid development through 1X. So humanoid robotics M&A is global in talent and assets, while the biggest commercial and capital-market signals remain heavily US-linked.

If you want more recent data on this point, please see our latest humanoid robotics market report.

Are adjacent robotics deals part of the humanoid robotics M&A story now?

Yes, adjacent robotics deals are part of the story, but they should stay outside the core humanoid robotics count. We should count 7 core humanoid deals, then use adjacent deals as context.

Serve Robotics / Diligent Robotics is the best adjacent example. Diligent’s Moxi operates around humans in hospitals, has completed more than 1.25M deliveries, and was acquired in a deal valuing Diligent common stock at $29M. That is relevant because it shows demand for robots working in human environments, but Moxi is not a bipedal humanoid.

Skild AI buying Zebra’s robotics automation business is another useful data point. Skild is building a general robot brain, while Zebra’s robotics assets are more about warehouse automation and fleet operations. SoftBank buying ABB Robotics is much larger and shows serious interest in physical AI, but ABB Robotics is still mainly industrial automation, not humanoid robotics.

At the end of the day, these adjacent deals tell us that physical AI is heating up around humanoids, even if they should not inflate the humanoid M&A count.

What is the latest update on humanoid robotics M&A now?

The latest update is that humanoid robotics M&A has entered its first real strategic consolidation phase. The deal count is still small, but the last 12 months brought more buyers, bigger disclosed values, more AI-platform logic, and a first public-market benchmark.

Check	Current status
Recent deal count	Humanoid robotics M&A had 7 core deals in 24 months. That is still a young market, but it is enough to show that strategic buying has started.
12-month momentum	Deal count rose from 2 deals in the previous 12 months to 5 deals in the last 12 months. That is a 2.5x increase, with most activity concentrated in early 2026.
Buyer quality	The buyer list improved sharply. Recent acquirers include Mobileye, Amazon, Meta, AVITA, Hugging Face, and public-market capital through Churchill.
Disclosed value	Only 2 of 7 core deals disclosed meaningful values, but those two total $3.4B: Mentee at $900M and Agility at $2.5B pre-money.
Disclosure level	Disclosure remains weak, with only about 29% of core deals disclosing value. That makes classic valuation multiples mostly unavailable.
Deal motivation	Buyers are buying future control more than current revenue. The main assets are robot platforms, AI talent, autonomy stacks, deployment data, and manufacturing optionality.
Body vs brain	Physical robot platforms still matter, but the intelligence layer is becoming more strategic. Meta / ARI and Mobileye / Mentee make that shift visible.
Commercial proof	Commercial traction is starting to separate stronger assets from pure demos. Agility’s orders, operating hours, customer facilities, and pipeline make it the clearest example.
Public-market signal	Agility / Churchill creates the first real public-market benchmark for US humanoid robotics. That gives investors a cleaner way to price the category.
Adjacent activity	Adjacent robotics deals like Serve / Diligent and Skild / Zebra show that physical AI is heating up around humanoids. They matter for context, but they should not be counted as core humanoid M&A.

Who is the author of this content?

NEW MARKET PITCH TEAM

We track new markets so founders and investors can move faster

We build living "market pitch" documents for emerging markets: AI, synthetic biology, new proteins, and more. Instead of outdated PDFs or hallucinated LLM answers, our clients get a clean, visual, always-updated view of what's really happening: key players, deals, regulations, and signals that matter. Learn more about us.